Translate
Oculis Holding Ag
About
Oculis Holding Ag — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
Mar 31 2026
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
Mar 16 2026
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
Mar 5 2026
Oculis to Participate in Upcoming Investor Conferences
Mar 3 2026
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
Recent Videos
Oculis révolutionne les injections ophtalmiques par des gouttes innovantes
Apr 14, 2026
Discover the news scale-up : OCULIS
Apr 13, 2026
Grow Your Business with the Right Revenue Attribution software
Mar 30, 2026
Oculis Holding AG (OCS) #FDA_Breakthrough #Treatment_of_Optic_Neuritis #significantUnmetMedicalNeeds
Jan 22, 2026